How much revenue does Auro Laboratories make?

Auro Laboratories reported 191.24 million INR in revenue for fiscal year 2025, down 63.7% from 527.00 million INR in fiscal year 2024. In Q3 2026 revenue was 93.93 million INR.

What companies are similar to Auro Laboratories?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO), Sanjivani Paranteral Limited (SANJIVIN.BO), Medico Remedies Limited (MEDICO.NS), Gujarat Inject (Kerala) Ltd (GUJINJEC.BO).

Auro Laboratories Limited (AUROLAB.BO) Stock

About Auro Laboratories Limited

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India and internationally. It offers antihistamine; muscle relaxant; diuretic; iron deficiency; anti-diabetic; anti-fungal, ulcer, malaria, and inflammatory; iodine supplement; analgesics; antacids; potassium and sodium iodide; and microcrystalline cellulose. The co...

At a glance

Auro Laboratories reported revenue of 191.24 million INR for fiscal year 2025, down 63.7% from fiscal year 2024, and net income of 18.39 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 93.93 million INR, up 207.5% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.